Imaging Technology

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Healthcare 88

Healthcare Healthcare Radiation Oncology Radiation 88

Imaging Technology

JULY 27, 2023

The company is a pre-clinical stage biotech company focused on advancing the field of radiation oncology through accelerator-based Boron Neutron Capture Therapy (BNCT), based in Santa Monica, CA. Hill joined TAE Life Sciences as Chief Operating Officer (COO) in October 2018.

Radiation Oncology 73

Radiation Oncology Radiation Pharmaceutical Clinic 73

AuntMinnie

JULY 11, 2023

Pharmaceutical industry companies were involved in payments to diagnostic radiolog.

Radiation Oncology 40

Radiation Oncology Diagnostic Pharmaceutical Medicare 40

Imaging Technology

APRIL 2, 2024

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. Together, we'll strive to continue our shared legacy of enhancing patient care. Oncotarget. 2017 Jun 8;8(37):62742-62758.

Healthcare 93

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 93

AuntMinnie

JANUARY 24, 2024

TerraPower Isotopes has shipped its first samples of Actinium-225 (Ac-225) to two pharmaceutical companies to develop targeted cancer treatments in drug trials. Ac-225 is an alpha-emitting radionuclide that can be attached to a ligand that binds to cancer cells.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Radiation Oncology IT 52

AuntMinnie

MARCH 14, 2024

Clarity Pharmaceuticals has completed its third cohort in the theranostic SECuRE trial evaluating copper-64 (Cu-64) and copper-67 (Cu-67) sarcophagine chelator technology in patients with metastatic castration-resistant prostate cancer.

Pharmaceutical 52

Pharmaceutical Diagnostic Radiation Oncology IT 52

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology. led by Harshad Kulkarni, MD, as principal investigator.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105